Literature DB >> 16086044

Characteristics and correlates of cognitive functioning following bone marrow transplantation.

M Booth-Jones1, P B Jacobsen, S Ransom, E Soety.   

Abstract

Patients who undergo bone marrow transplantation (BMT) often report cognitive problems following treatment. This study used cognitive tests and a self-report measure of subjective cognitive complaints to determine (1) the rate of objective cognitive impairment in a sample of 65 BMT patients, and (2) the correspondence of patients' cognitive complaints to their actual cognitive performance. At 6 months following BMT, patients were assessed in seven cognitive domains--attention, verbal learning, verbal memory, visual memory, simple executive function, complex executive function, and psychomotor speed. Cognitive complaints were likewise assessed. In all, 51% had at least mild impairment (-1 standard deviation (s.d.) below published norms) in one or more cognitive domains, with 28% demonstrating moderate-to-severe impairment (-2 s.d.). Older patients and patients with lower IQ were more likely to score in the impaired range on objective cognitive tests, with males and the less educated showing trends toward scores in the impaired range. Younger patients made significantly more cognitive complaints. Total cognitive complaints were unrelated to average cognitive performance, and complaints in specific cognitive domains were largely unrelated to objective performance on corresponding domains. Findings suggest that patients who complain about their cognitive performance following BMT differ from those who experience actual deficits.

Entities:  

Mesh:

Year:  2005        PMID: 16086044     DOI: 10.1038/sj.bmt.1705108

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  30 in total

1.  Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.

Authors:  Heather S L Jim; Brent Small; Sheri Hartman; Jamie Franzen; Shannon Millay; Kristin Phillips; Paul B Jacobsen; Margaret Booth-Jones; Joseph Pidala
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

Review 2.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

3.  Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation.

Authors:  Linda J Burns; Beatrice Abbetti; Stacie D Arnold; Jeffrey Bender; Susan Doughtie; Areej El-Jawahiri; Gloria Gee; Theresa Hahn; Mary M Horowitz; Shirley Johnson; Mark Juckett; Lakshmanan Krishnamurit; Susan Kullberg; C Fred LeMaistre; Alison Loren; Navneet S Majhail; Elizabeth A Murphy; Doug Rizzo; Alva Roche-Green; Wael Saber; Barry A Schatz; Kim Schmit-Pokorny; Bronwen E Shaw; Karen L Syrjala; D Kathryn Tierney; Christina Ullrich; David J Vanness; William A Wood; Ellen M Denzen
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-03       Impact factor: 5.742

4.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Hematol Oncol Stem Cell Ther       Date:  2012

5.  A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors.

Authors:  Lisa M Wu; Nadia Kuprian; Krista Herbert; Ali Amidi; Jane Austin; Heiddis Valdimarsdottir; Christine Rini
Journal:  Palliat Support Care       Date:  2019-08

6.  Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant.

Authors:  Lisa M Wu; Jane Austin; Jada G Hamilton; Heiddis Valdimarsdottir; Luis Isola; Scott Rowley; Rachel Warbet; Gary Winkel; William H Redd; Christine Rini
Journal:  Psychooncology       Date:  2011-07-08       Impact factor: 3.894

7.  Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation.

Authors:  S Mayo; H A Messner; S B Rourke; D Howell; J C Victor; J Kuruvilla; J H Lipton; V Gupta; D D Kim; C Piescic; D Breen; A Lambie; D Loach; F V Michelis; N Alam; J Uhm; L McGillis; K Metcalfe
Journal:  Bone Marrow Transplant       Date:  2016-02-29       Impact factor: 5.483

Review 8.  Psychiatric Care in Hematopoietic Stem Cell Transplantation.

Authors:  Zev M Nakamura; Rebekah P Nash; Laura J Quillen; Daniel R Richardson; Rebecca C McCall; Eliza M Park
Journal:  Psychosomatics       Date:  2019-01-19       Impact factor: 2.386

9.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Bone Marrow Transplant       Date:  2012-03       Impact factor: 5.483

10.  A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients.

Authors:  D D Correa; J C Root; R Baser; D Moore; K K Peck; E Lis; T B Shore; H T Thaler; A Jakubowski; N Relkin
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.